Browsing by Author "Menéndez Menéndez, Javier Abel"

Browsing by Author "Menéndez Menéndez, Javier Abel"

scopusId Menéndez Menéndez, Javier Abel

Now showing items 1-24 of 52

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)

2007 Article

Ferrer Soler, Laura Vázquez Martín, Alejandro Brunet i Vidal, Joan Menéndez Menéndez, Javier Abel et al.

Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling

2008 Article

Oliveras Ferrarós, Cristina Vázquez Martín, Alejandro Colomer, Ramon Llorens Duran, Rafael de et al.

Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models

2011 Article

Oliveras Ferrarós, Cristina Vázquez Martín, Alejandro Queralt, Bernardo Adrados, Manuel et al.

Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands

2012 Article

Carrion Salip, Dolors Panosa Roqueta, Clara Menéndez Menéndez, Javier Abel Puig i Miquel, Teresa et al.

Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment

2012 Article

Oliveras Ferrarós, Cristina Massaguer i Vall-llovera, Anna Vázquez Martín, Alejandro Carrion Salip, Dolors et al.

Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts

2012-04 Article

Cufí González, Sílvia Corominas Faja, Bruna Vázquez Martín, Alejandro Oliveras Ferrarós, Cristina et al.

Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d'un nou subtipus de càncer de mama (Basal/ErbB2+)

2013-06-21 Thesis

Oliveras Ferrarós, Cristina

Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment

2014 Article

Menéndez Menéndez, Javier Abel Quirantes Piné, Rosa Rodríguez Gallego, Esther Cufí González, Sílvia et al.

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells

2014 Article

Corominas Faja, Bruna Cuyàs, Elisabet Gumuzio, Juan Bosch Barrera, Joaquim et al.

Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells

2015 Article

González-Bártulos, Marta Aceves Luquero, Clara Qualai, Jamal Cussó Forest, Olaf et al.

Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties

2015-05-13 Article

Cuyàs, Elisabet Martin Castillo, Begoña Corominas Faja, Bruna Massaguer i Vall-llovera, Anna et al.

Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype

2015-05-20 Article

Cuyàs, Elisabet Fernández Arroyo, Salvador Corominas Faja, Bruna Rodríguez Gallego, Esther et al.

Bioenergetics mechanism and autophagy in breast cancer stem cells

2015-05-22 Thesis

Cufí González, Sílvia

Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin

2016-03-03 Article

Bosch Barrera, Joaquim Sais, Elia Cañete Abajo, Noemí Marruecos, Jordi et al.

Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer

2016-09-12 Article

Queralt, Bernardo Cuyàs, Elisabet Bosch Barrera, Joaquim Massaguer i Vall-llovera, Anna et al.

BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells

2017 Article

Cuyàs, Elisabet Corominas Faja, Bruna Muñoz San Martín, María Martin Castillo, Begoña et al.

Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity

2017-10-15 Article

Cuyàs, Elisabet Verdura, Sara Fernández Arroyo, Salvador Bosch Barrera, Joaquim et al.

Silibinin is a direct inhibitor of STAT3

2018-06-01 Article

Verdura, Sara Cuyàs, Elisabet Llorach Parés, Laura Pérez Sánchez, Almudena et al.

Metformin directly targets the H3K27me3 demethylase KDM6A/UTX

2018-08-01 Article

Cuyàs, Elisabet Verdura, Sara Llorach Parés, Laura Fernández-Arroyo S et al.

Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma

2018-08-31 Article

Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter et al.

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

2018-11-02 Article

Martin Castillo, Begoña Pernas, Sonia Dorca, Joan Álvarez, Isabel et al.

Metformin is a direct SIRT1-activating compound: computational modeling and experimental validation

2018-11-06 Article

Cuyàs, Elisabet Verdura, Sara Llorach Parés, Laura Fernández Arroyo, Salvador et al.

An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors

2019-01 Article

Verdura, Sara Cuyàs, Elisabet Lozano Sánchez, Jesús Bastidas-Velez, Cristian et al.

The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism

2019-02-27 Article

Guiducci, Giulia Paone, Alessio Tramonti, Angela Giardina, Giorgio et al.

Now showing items 1-24 of 52